|
NRAS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.200810E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.144620E-03 |
| Normal-vs-Stage2 |
6.42599999999272E-05 |
| Normal-vs-Stage3 |
3.018400E-04 |
| Normal-vs-Stage4 |
1.62003999999438E-05 |
| Stage1-vs-Stage2 |
1.671430E-01 |
| Stage1-vs-Stage3 |
4.788600E-01 |
| Stage1-vs-Stage4 |
5.967900E-02 |
| Stage2-vs-Stage3 |
5.293600E-01 |
| Stage2-vs-Stage4 |
5.437600E-01 |
| Stage3-vs-Stage4 |
2.451200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.54500000000879E-05 |
| Normal-vs-AfricanAmerican |
7.156000E-02 |
| Normal-vs-Asian |
4.4590000000011E-05 |
| Caucasian-vs-AfricanAmerican |
4.981200E-01 |
| Caucasian-vs-Asian |
2.176000E-01 |
| AfricanAmerican-vs-Asian |
1.494840E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.770450E-04 |
| Normal-vs-Female |
2.383100E-04 |
| Male-vs-Female |
5.136800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.455900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.87920000005448E-07 |
| Normal-vs-Age(61-80Yrs) |
2.607400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.938800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.896520E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.169240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.750600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.834000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.518220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.565400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.773600E-01 |
| Classical-VS-Follicular |
3.962100E-02 |
| Classical-VS-Other |
1.207800E-01 |
| Classical-VS-Normal |
1.623050E-03 |
| Tall-VS-Follicular |
1.854240E-01 |
| Tall-VS-Other |
1.679770E-01 |
| Tall-VS-Normal |
4.703800E-02 |
| Follicular-VS-Other |
3.650200E-01 |
| Follicular-VS-Normal |
1.75208999999565E-05 |
| Other-VS-Normal |
1.961700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.5000999999959E-06 |
| Normal-vs-N1 |
3.58099999999695E-05 |
| N0-vs-N1 |
5.568600E-01 |
|
|
